Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-04

Clinical Trial Update: A Study of KCT-0809 in Patients With Dry Eye Syndromes [Phase 2]

View source ↗

Summary

A Phase 2 trial of KCT-0809 for dry eye syndromes has completed, with the study status listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KCT-0809

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED